|Fourth Quarter 2016 Press Release|
Data provided by Nasdaq. Minimum 15 minutes delayed.
David Moatazedi Joins Obalon Therapeutics, Inc. Board of Directors
Obalon Therapeutics, Inc. Announces Fourth Quarter and Full Year 2016 Financial Results
Obalon Therapeutics Inc Announces Fourth Quarter and Year End 2016 Financial Results Conference Call
Obalon Therapeutics, Inc. to Ring The Nasdaq Stock Market Closing Bell
|There are currently no events scheduled.|